Your browser doesn't support javascript.
loading
Patient-reported outcomes in schizophrenia patients treated with once-monthly extended-release risperidone in a long-term clinical study.
Dhanda, Rahul; Varghese, Della; Nadipelli, Vijay R; Fava, Maurizio; Joshi, Namita; Solem, Caitlyn T; Graham, James A; Learned, Susan M; Heidbreder, Christian.
Affiliation
  • Dhanda R; Global Health Economics and Outcomes Research, Indivior Inc, Richmond, VA 23235, USA.
  • Varghese D; Real-World Evidence and Data Analytics, Pharmerit International, Bethesda, MD 20814, USA.
  • Nadipelli VR; Global Health Economics and Outcomes Research, Indivior Inc, Richmond, VA 23235, USA.
  • Fava M; Clinical Trials Network Institute (CTNI), Massachusetts General Hospital (MGH) and Harvard Medical School, Boston, MA 02114, USA.
  • Joshi N; Real-World Evidence and Data Analytics, Pharmerit International, Bethesda, MD 20814, USA.
  • Solem CT; Real-World Evidence and Data Analytics, Pharmerit International, Bethesda, MD 20814, USA.
  • Graham JA; Global Medicines Development, Indivior Inc, Richmond, VA 23235, USA.
  • Learned SM; Global Medicines Development, Indivior Inc, Richmond, VA 23235, USA.
  • Heidbreder C; Global Research and Development, Indivior Inc, Richmond, VA 23235, USA.
Patient Prefer Adherence ; 13: 1037-1050, 2019.
Article in En | MEDLINE | ID: mdl-31308636
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Patient Prefer Adherence Year: 2019 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Patient Prefer Adherence Year: 2019 Type: Article Affiliation country: United States